Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALAFree Report) in a report published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of CALA opened at $0.03 on Monday. Calithera Biosciences has a one year low of $0.01 and a one year high of $0.50. The stock’s fifty day moving average is $0.02 and its 200-day moving average is $0.03.

About Calithera Biosciences

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Recommended Stories

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.